Petersen M, Alfermann A W
Institut für Pharmazeutische Biologie, Philipps-Universität Marburg, Germany.
Appl Microbiol Biotechnol. 2001 Mar;55(2):135-42. doi: 10.1007/s002530000510.
Cytotoxic lignans derived from podophyllotoxin are currently used in cancer chemotherapy. Podophyllotoxin for semi-synthetic derivatization is isolated from the rhizomes of Podophyllum plants growing wild, some of which are counted as endangered species. An alternative source for podophyllotoxin or related lignans may in future be cell cultures derived from different plant species, such as Podophyllum spp or Linum spp. These cell cultures were shown to accumulate considerable amounts of podophyllotoxin or 5-methoxypodophyllotoxin. Optimization of the cell cultivation regime might lead to a renewable source of cytotoxic lignans for medicinal uses. This Mini-Review summarizes the attempts to establish plant cell cultures for the production of podophyllotoxin and related lignans and their optimization towards high levels of these target compounds. It also summarizes the results of studies on the biosynthesis of podophyllotoxin and 5-methoxypodophyllotoxin.
源自鬼臼毒素的细胞毒性木脂素目前用于癌症化疗。用于半合成衍生化的鬼臼毒素是从野生的鬼臼属植物的根茎中分离得到的,其中一些被列为濒危物种。未来,鬼臼毒素或相关木脂素的替代来源可能是来自不同植物物种的细胞培养物,如鬼臼属植物或亚麻属植物。这些细胞培养物已被证明能积累大量的鬼臼毒素或5-甲氧基鬼臼毒素。优化细胞培养条件可能会产生用于药用的细胞毒性木脂素的可再生来源。本综述总结了建立用于生产鬼臼毒素和相关木脂素的植物细胞培养物的尝试以及对这些目标化合物高水平合成的优化。它还总结了关于鬼臼毒素和5-甲氧基鬼臼毒素生物合成的研究结果。